The SPARTAC Trial Investigators: Short-Program Antiretroviral Therapy in Principal HIV Infection Although the use of highly active antiretroviral therapy in human immunodeficiency virus disease decreases morbidity and mortality,1-3 the function of ART in the management of primary HIV infection remains controversial.4-6 Immunologic damage after HIV acquisition occurs rapidly and is not wholly reversible by later ART http://www.cialisreviews.com/contact-us . 7-9 Observational studies have suggested that a short span of ART during major HIV infection might preserve immune function,10,11 decrease viral development,12 and limit the viral reservoir.16,17 However, there is currently no proof from randomized trials on whether initiating ART during primary HIV infection delays disease progression.
In response to each allergen, the immune system produces a specific form of immunoglobulin E that can trigger allergies. By quantifying specific IgE, ImmunoCAP not merely determines whether one is allergic and to what, but also suggests how severe each allergy is. An unrestricted grant from Pharmacia Diagnostics, the maker of the ImmunoCAP test, supported the research.. 62 % of frequent antihistamine users did not test positive for allergies A new study in the current problem of Journal of Managed Care Pharmacy concludes that 62 % of frequent antihistamine users didn’t test positive for allergies. The authors recommend that objective analysis with an allergen-specific IgE test may yield more appropriate clinical management, reduce office appointments and improve patients’ standard of living.